NCT01053728 Study of How Single Rising Doses of SAR161271 Are Absorbed and Act in Patients With Type 1 Diabetes Mellitus (T1DM) Status COMPLETED Phase PHASE1/PHASE2
NCT01053702 Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Pain Resulting From Thermal Injury Status WITHDRAWN Phase PHASE2
NCT01049425 Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer Status COMPLETED Phase PHASE3
NCT01047566 Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE) Status COMPLETED Phase PHASE4
NCT01045304 Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT01044485 Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01042925 Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen Status COMPLETED Phase PHASE1/PHASE2
NCT01038661 Tax First-line Chemotherapy With Different Doses and Then Maintenance Therapy Status COMPLETED Phase PHASE3
NCT01038011 Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study Status COMPLETED Phase PHASE2
NCT01034995 A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT01033292 A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01033123 A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01031303 Immunogenicity and Safety of TETRAXIMâ„¢ Given as a Booster Dose at 4 to 6 Years of Age Status COMPLETED Phase PHASE4
NCT01026597 Ascending Dose Study of the Safety and Tolerability of REGN727(SAR236553) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01026519 A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01026090 Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA) Status TERMINATED Phase PHASE4
NCT01024192 Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA Status COMPLETED Phase PHASE4
NCT01021150 Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid Tumors Status COMPLETED Phase PHASE1